PLC-ε1 Gene Polymorphisms Significantly Enhance the Risk of Esophageal Squamous Cell Carcinoma in Individuals with a Family History of Upper Gastrointestinal Cancers

Archives of Medical Research

Volumn 43, Issue 7, 2012, Pages 578-584

  Zhou, Rong Miao ^a   Li, Yan ^a   Wang, Na ^a   Liu, Bao Chen ^b   Chen, Zhi Feng ^a   Zuo, Lian Fu ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Botou Vocational College   (China)

Author keywords

Esophageal squamous cell carcinoma; PLC 1; Polymorphism; Upper gastrointestinal cancer

Indexed keywords

DNA; PHOSPHOLIPASE C; PHOSPHOLIPASE C EPSILON1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DNA SEQUENCE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CARCINOMA; FAMILY HISTORY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LIGASE DETECTION REACTION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHINA; ESOPHAGEAL NEOPLASMS; FEMALE; GASTROINTESTINAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PHOSPHOINOSITIDE PHOSPHOLIPASE C; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84869794495     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2012.09.006     Document Type: Article

References (32)

1. Parkin D.M., Bray F., Ferlay J., et al. Global cancer statistics. CA Cancer J Clin 2005, 55:74-108.
2. Ke L. Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa 1970-90. Int J Cancer 2002, 102:271-274.
3. Coleman M.P., Gatta G., Verdecchia A., et al. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol 2003, 14(suppl 5):v128-v149.
4. Munoz N., Day N.E. Esophageal cancer. Cancer Epidemiology and Prevention 1996, 681-706. Oxford University Press, New York. 2nd ed. D. Schottenfeld, J.F. Fraumeni (Eds.).
5. Siassi F., Ghadirian P. Riboflavin deficiency and esophageal cancer: a case control-household study in the Caspian Littoral of Iran. Cancer Detect Prev 2005, 29:464-469.
6. Yang C.X., Wang H.Y., Wang Z.M., et al. Risk factors for esophageal cancer: a case-control study in South-western China. Asian Pac J Cancer Prev 2005, 6:48-53.
7. Sun G., Wang S., Hu X., et al. Fumonisin B1 contamination of home-grown corn in high-risk areas for esophageal and liver cancer in China. Food Addit Contam 2007, 24:181-185.
8. Guohong Z., Min S., Duenmei W., et al. Genetic heterogeneity of oesophageal cancer in high-incidence areas of southern and northern China. PLoS One 2010, 5:e9668.
9. Zhang W., Bailey-Wilson J.E., Li W., et al. Segregation analysis of esophageal cancer in a moderately high-incidence area of northern China. Am J Hum Genet 2000, 67:110-119.
10. Li Y., Sun D.L., Duan Y.N., et al. Association of functional polymorphisms in MMPs genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in a high incidence region of North China. Mol Biol Rep 2010, 37:197-205.
11. Wang N., Dong X.J., Zhou R.M., et al. An investigation on the polymorphisms of two DNA repair genes and susceptibility to ESCC and GCA of a high-incidence region in northern China. Mol Biol Rep 2009, 36:357-364.
12. Manolio T.A. Genomewide association studies and assessment of the risk of disease. N Engl J Med 2010, 363:166-176.
13. Hirschhorn J.N., Daly M.J. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 2005, 6:95-108.
14. Wang L.D., Zhou F.Y., Li X.M., et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet 2010, 42:759-763.
15. Abnet C.C., Freedman N.D., Hu N., et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet 2010, 42:764-767.
16. Zhang H., Jin G., Li H., et al. Genetic variants at 1q22 and 10q23 reproducibly associated with gastric cancer susceptibility in a Chinese population. Carcinogenesis 2011, 32:848-852.
17. Wu C., Hu Z., He Z., et al. Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nat Genet 2011, 43:679-684.
18. Hu H., Yang J., Sun Y., et al. Putatively functional PLCE1 variants and susceptibility to esophageal squamous cell carcinoma (ESCC): a case-control study in Eastern Chinese populations. Ann Surg Oncol 2012, 19:2403-2410.
19. Kelley G.G., Reks S.E., Ondrako J.M., et al. Phospholipase C (epsilon): a novel Ras effector. EMBO J 2001, 20:743-754.
20. Song C., Hu C.D., Masago M., et al. Regulation of a novel human phospholipase C, PLCepsilon, through membrane targeting by Ras. J Biol Chem 2001, 276:2752-2757.
21. Song C., Satoh T., Edamatsu H., et al. Differential roles of Ras and Rap1 in growth factor-dependent activation of phospholipase C epsilon. Oncogene 2002, 21:8105-8113.
22. Schmidt M., Evellin S., Weernink P.A., et al. A new phospholipase-C-calcium signalling pathway mediated by cyclic AMP and a Rap GTPase. Nat Cell Biol 2001, 3:1020-1024.
23. Bai Y., Edamatsu H., Maeda S., et al. Crucial role of phospholipase Cepsilon in chemical carcinogen-induced skin tumor development. Cancer Res 2004, 64:8808-8810.
24. Oka M., Edamatsu H., Kunisada M., et al. Enhancement of ultraviolet B-induced skin tumor development in phospholipase Cε-knockout mice is associated with decreased cell death. Carcinogenesis 2010, 31:1897-1902.
25. Li M., Edamatsu H., Kitazawa R., et al. Phospholipase Cepsilon promotes intestinal tumorigenesis of Apc (Min/+) mice through augmentation of inflammation and angiogenesis. Carcinogenesis 2009, 30:1424-1432.
26. Sorli S.C., Bunney T.D., Sugden P.H., et al. Signaling properties and expression in normal and tumor tissues of two phospholipase C epsilon splice variants. Oncogene 2005, 24:90-100.
27. Bourguignon L.Y., Gilad E., Brightman A., et al. Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells. J Biol Chem 2006, 281:14026-14040.
28. Ou L., Guo Y., Luo C., et al. RNA interference suppressing PLCE1 gene expression decreases invasive power of human bladder cancer T24 cell line. Cancer Genet Cytogenet 2010, 200:110-119.
29. Ma H., Wang L.E., Liu Z., et al. Association between novel PLCE1variants identified in published esophageal cancer genome-wide association studies and risk of squamous cell carcinoma of the head and neck. BMC Cancer 2011, 11:258.
30. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215.
31. Tran G.D., Sun X.D., Abnet C.C., et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 2005, 113:456-463.
32. Ikuta S., Edamatsu H., Li M., et al. Crucial role of phospholipase C epsilon in skin inflammation induced by tumor-promoting phorbol ester. Cancer Res 2008, 68:64-72.